(Q37245232)

19 August 2017

Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists (English)

1 reference

19 August 2017

1 reference

1 reference

1 reference

7

Marla Dubinsky

1 reference

19 August 2017

4

Stephan Targan

1 reference

19 August 2017

Brennan M R Spiegel

1

1 reference

19 August 2017

Wayne Ho

2

1 reference

19 August 2017

Eric Esrailian

3

1 reference

19 August 2017

Peter D R Higgins

5

1 reference

19 August 2017

Corey A Siegel

6

1 reference

19 August 2017

Gil Y Melmed

8

1 reference

19 August 2017

language of work or name

English

0 references

publication date

4 September 2008

1 reference

Clinical Gastroenterology and Hepatology

19 August 2017

1 reference

19 August 2017

7

1 reference

19 August 2017

2

1 reference

19 August 2017

168-74, 174.e1

1 reference

Quality of life of patients with ulcerative colitis: past, present, and future

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: a nested, case-control study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

Systematic review: the use of mesalazine in inflammatory bowel disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

Prevention of colorectal cancer in inflammatory bowel disease: value of screening and 5-aminosalicylates

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for 'best evidence'?

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

Guidelines for the management of inflammatory bowel disease in adults

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

Instruments for quality of life assessment in patients with inflammatory bowel disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

Defining and measuring quality of care: a perspective from US researchers

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

Impact of inflammatory bowel disease on health-related quality of life

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

Does inappropriate use explain geographic variations in the use of health care services? A study of three procedures

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

Differences in the management of Crohn's disease among experts and community providers, based on a national survey of sample case vignettes

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

Efficacy, effectiveness, variations, and quality. Boundary-crossing research

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

How well does chart abstraction measure quality? A prospective comparison of standardized patients with the medical record

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

Management of steroid-dependent ulcerative colitis: immunomodulatory agents, biologics, or surgery?

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

Measuring the quality of physician practice by using clinical vignettes: a prospective validation study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804428

Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial man

3 September 2018

1 reference

12 December 2020

Variations in Processes and Structures of Cardiac Surgery Practice

1 reference

12 December 2020

Assessing clinical performance with standardized patients

1 reference

12 December 2020

Practice variations and health care reform: connecting the dots

1 reference

12 December 2020

Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up

1 reference

12 December 2020

SSAT patient care guidelines. Management of ulcerative colitis

1 reference

12 December 2020

10.1016/J.CGH.2008.08.029

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

18952199

1 reference